Sign up to save your podcasts
Or
Share Insights from RESHAPE-HF2 Trial | ESC 2024
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Insights from RESHAPE-HF2 Trial | ESC 2024
Aakriti Gupta, MD, FACC, JACC Executive Associate Editor, and Stefan D. Anker, MD, discuss the insights from the RESHAPE-HF2 trial - an eight-year study on the efficacy of transcatheter edge-to-edge repair for mitral valve regurgitation in patients with heart failure.
View all episodes
By American College of Cardiology
4.2
162162 ratings
Aakriti Gupta, MD, FACC, JACC Executive Associate Editor, and Stefan D. Anker, MD, discuss the insights from the RESHAPE-HF2 trial - an eight-year study on the efficacy of transcatheter edge-to-edge repair for mitral valve regurgitation in patients with heart failure.
More shows like JACC This Week
View all
JAMA Editors' Summary
135 Listeners
NEJM This Week
320 Listeners
JAMA Clinical Reviews
499 Listeners
This Week in Cardiology
886 Listeners
JACC Specialty Journals
19 Listeners
Circulation on the Run
32 Listeners
The Curbsiders Internal Medicine Podcast
3,360 Listeners
Eagle's Eye View: Your Weekly CV Update From ACC.org
139 Listeners
Core IM | Internal Medicine Podcast
1,142 Listeners
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
62 Listeners
ACC CardiaCast
40 Listeners
Annals On Call Podcast
198 Listeners
JAMA Medical News
91 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
368 Listeners
Cardionerds: A Cardiology Podcast
427 Listeners